In a combined cohort of 234 individuals with biallelic GJB2 mutations, mild (4.5%) and moderate (13.3%) hearing loss accounted for only a small fraction of cases, whereas 14.9% exhibited severe hearing loss, and the majority (25%) had profound deafness. Here, GJB2 is linked to hearing loss disorder.